See the DrugPatentWatch profile for rexulti
Rexulti is not currently available as a generic drug. The brand-name medication is manufactured by Otsuka Pharmaceutical and Lundbeck [1].
When might generic Rexulti become available?
The patent landscape for Rexulti, like many branded pharmaceuticals, involves various patents covering its composition, methods of use, and manufacturing processes. The expiration of these patents is a critical factor in determining when generic versions can enter the market. Information regarding specific patent expiry dates and any ongoing legal challenges can be found on resources like DrugPatentWatch.com [2].
What is Rexulti used for?
Rexulti (brexpiprazole) is prescribed to treat major depressive disorder (MDD) as an add-on therapy and to manage symptoms of schizophrenia in adults and in adolescents aged 13 and older [3]. It is classified as an atypical antipsychotic [4].
How does Rexulti work?
Rexulti works by affecting the activity of neurotransmitters in the brain, primarily serotonin and dopamine. It acts as a partial agonist at serotonin 5-HT1A and dopamine D2 receptors, and as an antagonist at serotonin 5-HT2A and alpha2C adrenergic receptors [4]. This mechanism helps to rebalance brain chemistry, which can alleviate symptoms of depression and schizophrenia [3].
What are the alternatives to Rexulti?
For major depressive disorder, alternatives to add-on therapy with Rexulti include other atypical antipsychotics, certain antidepressants, or different therapeutic approaches such as psychotherapy. For schizophrenia, other antipsychotic medications, both typical and atypical, are available [5].
Who makes Rexulti?
Otsuka Pharmaceutical and Lundbeck are the companies that developed and market Rexulti [1].